CNBC: Pfizer’s new at-home pill to treat COVID could be available by end of the year, CEO hopes

Now that the nation has opened up vaccines for the general public and vaccine companies have produced optimistic news about the safety of vaccines in adolescents and children, Pfizer has began to develop a new form of treatment. Their new treatment, currently in Phase 1, is an oral pill used to treat COVID-19, and is part of a class of medicines called “protease inhibitors,” which are also used to treat other various viral pathogens including HIV and Hepatitis C.

 

Many people are afraid of injections and having another option available to them will increase our chances of reaching herd immunity. They are hoping to have the pill released by the end of 2021.

 

To read more about this new oral drug for COVID-19, click here for a short article by Berkeley Lovelace from CNBC. To read one of our original articles about COVID-19 and antimicrobial resistance written by Nazrin Rustamzade, click here.